Reviewed by John M. Grohol, Psy.D. on October 14, 2011
Elevated C-reactive protein (CRP) levels in patients with schizophrenia are associated with a higher 10-year risk for cardiovascular disease, new research suggests.
Past studies have shown that schizophrenia is associated with significant coexisting health concerns. This includes an increased risk for the metabolic syndrome — which is also a risk factor for cardiovascular disease (also known as heart disease).
Antoni Sicras-Mainar from Badalona Serveis Assistencials in Spain and colleagues conducted a cross-sectional analysis of administrative claims in 705 individuals who has a diagnosis of schizophrenia.
Read in Full:
Leave a Reply